A carregar...

Anti-estrogen therapy increases plasticity and cancer stemness of prolactin-induced ERα+ mammary carcinomas

Although anti-estrogen therapies are successful in many patients with estrogen receptor alpha-positive (ERα+) breast cancer, 25-40% fail to respond. Although multiple mechanisms underlie evasion of these treatments, including tumor heterogeneity and drug-resistant cancer stem cells (CSCs), further i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Shea, Michael P., O’Leary, Kathleen A., Fakhraldeen, Saja A., Goffin, Vincent, Friedl, Andreas, Wisinski, Kari B., Alexander, Caroline M., Schuler, Linda A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5882549/
https://ncbi.nlm.nih.gov/pubmed/29363543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-17-0985
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!